MSH6: Cancer Risks
Cancer Risks Associated with Inherited Mutations
People with an mutation have . mutations increase the risk for colorectal, endometrial and other types of cancer listed in the table below.
Experts at the National Comprehensive Cancer Network (NCCN) created guidelines which estimate the cancer risks for people with mutations. These cancer risk estimates are updated based on the latest research. It is important to note that cancer risks are estimates over the course of a person's lifetime. Your lifetime risk and risk over the next five years will vary depending on:
- current age.
- sex assigned at birth.
- specific mutation.
- personal and family health history.
- diet, exercise, lifestyle and other factors.
If you or a relative have tested positive for an mutation, we recommend speaking with a genetics expert. They can look at your personal and family medical history to help you understand and decide on a plan for managing your risk.
Cancer risk table
|
Cancer Type |
Lifetime Risk with an Mutation |
Lifetime Risk for General Population |
Average Age of Onset with |
Average Age of Onset in General Population |
|
Colorectal |
10 - 44% |
4% |
42 - 69 years |
68 - 72 years |
|
Endometrial |
16 - 49% |
3.1% |
53 - 55 years |
60 years |
|
Ovarian |
Up to 13% |
1.1% |
46 years |
63 years |
|
Kidney/ureter |
Up to 5.5% |
1.8% |
65 - 69 years |
Not specified |
|
Bladder |
Up to 8.2% |
2.2% |
71 years |
73 years |
|
Gastric |
<1 - 7.9% |
0.8% |
Limited data |
68 years |
|
Small bowel |
<1 - 4% |
0.3% |
54 years |
60s - 70s |
|
May be elevated |
12.8% |
63 years |
66 years |
|
|
Brain |
0.8 - 1.8% |
0.6% |
43 - 54 years |
59 years |
|
Biliary tract |
0.2 - 1.0% |
No data |
No data |
70 - 72 years |
|
Source: NCCN Guidelines: Genetic/Familiar High-Risk Assessment: Colorectal, Endometrial, Esophageal, Gastric; v.1 2026. |
||||
Other cancers
People with an inherited mutation may have an increased risk for other cancers. The exact risks for the following cancers are unknown:
- pancreatic cancer
- sebaceous skin growths
- female breast cancer
Research on how inherited mutations in the gene affect cancer risk is ongoing.
More Resources
Lynch Syndrome Research
This trial will study the safety, tolerability, and initial effectiveness...
ENGAGE: Surveys to Assess Decision-Making on Genetic Counseling and Testing for Lynch Syndrome
We are conducting a clinical trial to see if our...
Vaccine for People at High Risk for Pancreatic Cancer
This study is testing an experimental vaccine that helps the...
SCREEN-CUP: Menstrual Cup Screening for Endometrial Cancer in Lynch Syndrome
This study is looking at whether a menstrual cup can...
Using a Shorter Type of MRI as a Screening Tool for People at High Risk for Prostate Cancer
This study is looking at whether using a shorter type...
Post-surgery Immunotherapy (Toripalimab) for MMR-D / MSI-H Stage IIB-III Colon Cancer
This phase II trial evaluates how well immunotherapy (toripalimab) works...